Hypoglycaemia among adults with Type 2 Diabetes mellitus in a Family Medicine Clinic


  • OO Sodipo
  • AB Ademolu
  • S Odunaye-Badmus
  • EO Oluwatuyi
  • R Odiana




Dipeptidylpeptidase-4 Inhibitors, Dyslipidaemia, Hypertension, Hypoglycaemia, Insulin, Sulphonylurea


Background: The prevalence of Diabetes mellitus (DM) is increasing worldwide. The complications of DM arising from hyperglycaemia are well documented and. However, there is a lack of data, poor awareness and information on hypoglycaemia in DM.

Objective: To describe the prevalence and factors associated with hypoglycaemia among patients with Type 2 Diabetes mellitus (DM).

Methods: This was a retrospective study of the clinical records of patients with Type 2 DM at the Family Medicine Clinic of a Nigerian teaching hospital from January 2019 to January 2020. The sociodemographic and clinical characteristics, including hypoglycaemia, Glycosylated Haemoglobin (HbA1c), Fasting and Random blood glucose, were retrieved.

Results: A total number of 570 patients were assessed, with a prevalence of 43 (7.5%) of hypoglycaemia. The mean age of the patients in the study was 58.2±10.9 years (range: 36-83 years). Metformin (557; 97.7%), Sulphonylureas (377; 66.1%), Dipeptidylpeptidase -4 inhibitors (137; 24.0%) and insulin (72; 12.6%) were the most prescribed anti-diabetic medications. hypoglycaemiaA majority (29; 67.4%) of the hypoglycaemia episodes occurred in the morning, while most (24; 55.8%) of the episodes of hypoglycaemia were mild. Mean age (t= 2.35; p = 0.019), presence of hypertension (X2 = 6.92, p = 0.008) and dyslipidaemia (X2 = 7.86, p = 0.005) were associated with hypoglycaemia.

Conclusions: The prevalence of hypoglycaemia in the Outpatient clinic was low, while the presence of comorbidities                                   (hypertension and dyslipidaemia) and age were associated with hypoglycaemia. There is a need for patient education and Self-Monitoring of Blood Glucose (SMBG) to prevent complications of hypoglycaemia. hypoglycaemia


International Diabetes Federation. IDF Diabetes Atlas, 9th Edition. Brussels, Belgium: 2019. Available at: http://www.diabetesatlas.org/ Accessed on 20 December 2020.

Parati G, Bilo G, Ochoa JE. Benefits of tight blood pressure control in diabetic patients with hypertension. Diabetes Care. 2011; 34: S297-S303.https://doi.org/10.2337/dc11-s243

Fullerton B, Jeitler K, Seitz M, Horvath K, Berghold A, Siebenhofer A. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2014, Issue 2. Art. No.: CD009122. https://doi.org/10.1002/14651858.CD009122.pub2

Iloh GU, Amadi AN. Epidemiology of hypoglycaemia among ambulatory Type 2 diabetic patients in a primary care clinic of a tertiary hospital in Southeastern Nigeria. J Health Res Rev 2018; 5: 57-65. https://doi.org/10.4103/jhrr.jhrr_37_17

Birabwa C., Bwambale MF, Waiswa P. Quality and barriers of outpatient diabetes care in rural health facilities in Uganda – a mixed-methods study. BMC Health Serv Res .2019; 19: 706. https://doi.org/10.1186/s12913-019-4535-x

Ejegi A, Ross AJ, Naidoo K. Knowledge of symptoms and self-management of hypoglycaemia amongst patients attending a diabetic clinic at a regional hospital in KwaZulu-Natal. Afr J Pry Health Care Fam Med 2016; 8: e1-e6. https://doi.org/10.4102/phcfm.v8i1.906

Idowu AO, Adesegun OA, Osonuga A, Osibowale B, Ajiro T, Ngubor TD, et al. Patterns and Impact of Consultations to an Endocrinology Unit in a Tertiary Hospital in Southwestern Nigeria. Niger Med J 2018; 59: 28-32. https://doi.org/10.4103/nmj.NMJ_167_18

Abisoye OA, Oseribhor U. Prevalence and Presentation of Diabetes-Related Hypoglycaemia amongst Persons with Diabetes in a Tertiary Health Institution in Nigeria. Int J Diabetes Endocrinol. Special Issue: Hypoglycemia in Diabetes 2020; 5: 34-40. https://doi.org/10.11648/j.ijde.20200503.11

Besen BD, Arda Sürücü H, Kosar C. Self reported frequency, severity of, and awareness of hypoglycemia in type diabetes patients in Turkey. Peer J 2016; 4: e2700. https://doi.org/10.7717/peerj.2700

Patel A, MacMahon S, Chalmers J. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560-2572.

Duckworth W, Abraira C, Moritz T. VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360: 129-139.

Gerstein HC, Miller ME. Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008; 358: 2545-2559.

American Diabetes Association Workgroup on Hypoglycemia. Defining and Reporting Hypoglycemia in Diabetes: A report from the American Diabetes Association Workgroup of Hypoglycemia. Diabetes Care. 2005; 5: 1245-1249.

Ratzki-Leewing A, Harris SB, Mequanint S. Real-world crude incidence of hypoglycemia in adults with diabetes: Results of the In Hypo-DM Study, Canada. BMJ Open Diab Res Care 2018; 6: e000503. https://doi.org/10.1136/ bmjdrc-2017-000503

Leiter L, Yale J, Chiasson J. Assessment of the impact of fear of hypoglycemic episodes on glycemic and hypoglycemia management. Diabetes 2005; 29: 186–192.

International Hypoglycaemia Study Group: Glucose concentrations of less than 3.0 mmol/L (54 mg/dL) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2017; 40: 155–157. https://doi.org/10.2337/dc16-2215

Olamoyegun MA, Ayodele AO, Enikuomehin AC, Akinlade AT. Incidence and Determinants of Reported Hypoglycaemia among Patients with Type 2 Diabetes Mellitus in a Tertiary Health Institution in Nigeria. J Diabetes Mellitus 2020: 10; 51-63.

Schope D, Bramlage P, Binz C, Krekler M, Deeg E, Gitt AK. Incidence and predictors of hypoglycaemia in type 2 diabetes. An analysis of the prospective DiaRegis registry. BMC Endocr Disord 2012; 12: 23-30. https://doi.org/https://doi.org/10.1186/1472-6823-12-23

Samya V, Shriraam V, Jasmine A, et al. Prevalence of Hypoglycemia among patients with Type 2 Diabetes Mellitus in a Rural Health Center in South India. J Prim Care Community Health 2019; 10: 2150132719880638. https://doi.org/10.1177/2150132719880638

Quilliam BJ, Simeone JC, Ozbay AB, Kogut SJ. The incidence and costs of hypoglycemia in type 2 diabetes. Am J Manag Care. 2011; 17: 673-680.

Parsaik AK, Carter RE, Pattan V, Myers LA, Kumar H, Smith SA, et al. Population-based study of severe hypoglycemia requiring emergency medical service assistance reveals unique findings. J Diabetes Sci Technol 2012; 6: 65-73. https://doi.org/10.1177/193229681200600109

Hsu PF, Sung SH, Cheng HM, Yeh JS, Liu WL, Chan WL, et al. Association of clinical symptomatic hypoglycemia with cardiovascular events and total mortality in type 2 diabetes: a nationwide population-based study. Diabetes Care 2013; 36: 894-900. https://doi.org/10.2337/dc12-0916

Yang CM, Ma YL, Kang J , Jia Z, Wang YY. Time and department distribution of hypoglycemia occurrences in hospitalised diabetic patients. Int J Nurs Serv 2015: 9: 263-267. https://doi.org/10.1016/j.ijnss.2015.08.001

Shen LL, Zhang N. The situation analysis and nursing countermeasures of hypoglycaemia in hospitalised patients with diabetes. J Nurs 2012; 19(3A): 50e1. https://doi.org/10.1016/j.ijnss.2012.08.001

Ouyang SY, Wang QL, Wu XY. Hypoglycemia incidence survey hospitalised patients with diabetes. West China Med 2012; 27: 727e8.

Li DX, Song BY, Zhang LI, Ren L, Niu HY, Zhang H. 62 cases of type 2 diabetes patients in the intensive treatment characteristics analysis of hypoglycemia occurs. Chin J Nurs 2007; 42: 725e6.

Miller ME, Bonds DE, Gerslein HC, Seaquist ER, Bergenstal RM, Calles-Escandon J, et al. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. BMJ 2010; 340: 5444. https://doi.org/10.1136/bmj.b5444

Wong MG, Petkovic V, Chalmers J, Woodward M, Li Q, Cooper ME, et al. Long-term benefits of intensive glucose control for preventing end-stage kidney disease: ADVANCE-ON. Diabetes Care 2016; 39: 694-700. https://doi.org/10.2337/dc15-2322

Agarwal AA, Jadhav PR, Deshmukh YA. Prescribing pattern and efficacy of anti-diabetic drugs in maintaining optimal glycemic levels in diabetic patients. J Basic Clin Pharm.2014; 5: 79-83. https://doi.org/10.4103/0976-0105.139731

Ademolu BA. Sulfonylureas Induced Hypoglycemia in Diabetics - A Review. Int J Diabetes Endocrinol Special Issue: Hypoglycemia in Diabetes. 2019;.4: 109-112. https://doi.org/10.11648/j.ijde.20190404.14

Shriraam V, Mahadevan S, Anitharani M, Jagadeesh NS, Kurup SB, Vidya TA, et al. Reported hypoglycemia in Type 2 diabetes mellitus patients: Prevalence and practices-a hospital-based study. Indian J Endocrinol Metab 2017; 21: 148-153. https://doi.org/10.4103/2230-8210

Eriksson JW, Bodegard J, Nathanson D, Thuresson M, Nystro T, Norhammar A. Sulphonylurea compared to DPP-4 inhibitors in combination with metformin carries increased risk of severe hypoglycemia, cardiovascular events, and all-cause mortality. Diabetes Res Clin Pract.2016; 117: 39–4 7. https://doi.org/10.1016/j.diabres.2016.04.055

Signorovitch JE, Macaulay D, Diener M, Yan Y, Wu EQ, Gruenberger JB. Hypoglycaemia and accident risk in people with type 2 diabetes mellitus treated with non-insulin antidiabetes drugs. Diabetes Obes Metab 2013; 15: 335-341. https://doi.org/10.1111/dom.12031

Geller AI, Shehab N, Lovegrove MC, Kegler SR, Weidenbach KN, Ryan GJ, et al. National estimates of insulin-related hypoglycemia and errors leading to emergency department visits and hospitalisations. JAMA Intern Med 2014; 174: 678-686. https://doi.org/10.1001/jamainternmed.2014.136

Sami W, Ansari T, Butt NS, Hamid MRA. Effect of diet on type 2 diabetes mellitus: A review. Int J Health Sci 2017; 11: 65-67.






Original Research